These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20197627)

  • 1. Basic principles of platelet biology and clinical implications.
    Angiolillo DJ; Ueno M; Goto S
    Circ J; 2010 Apr; 74(4):597-607. PubMed ID: 20197627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet biology and implications for antiplatelet therapy in atherothrombotic disease.
    Montalescot G
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):371-80. PubMed ID: 20566574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of platelets and antiplatelet therapy in cardiovascular disease.
    Ueno M; Kodali M; Tello-Montoliu A; Angiolillo DJ
    J Atheroscler Thromb; 2011; 18(6):431-42. PubMed ID: 21427504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy for atherothrombotic disease: how can we improve the outcomes?
    Moser M; Bode C
    J Thromb Thrombolysis; 2010 Aug; 30(2):240-9. PubMed ID: 20467788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options.
    Fintel DJ
    Vasc Health Risk Manag; 2012; 8():77-89. PubMed ID: 22393298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The P2 receptors in platelet function.
    Hechler B; Cattaneo M; Gachet C
    Semin Thromb Hemost; 2005 Apr; 31(2):150-61. PubMed ID: 15852218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet therapy: thrombin receptor antagonists.
    Tello-Montoliu A; Tomasello SD; Ueno M; Angiolillo DJ
    Br J Clin Pharmacol; 2011 Oct; 72(4):658-71. PubMed ID: 21906120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet thrombin receptor antagonism and atherothrombosis.
    Angiolillo DJ; Capodanno D; Goto S
    Eur Heart J; 2010 Jan; 31(1):17-28. PubMed ID: 19948715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.
    Wilson JM; Ferguson JJ
    Clin Cardiol; 1999 Nov; 22(11):687-98. PubMed ID: 10554682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet function testing and implications for clinical practice.
    Collet JP; Montalescot G
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):157-69. PubMed ID: 19721130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of galectins as novel regulators of platelet signaling and function.
    Romaniuk MA; Negrotto S; Campetella O; Rabinovich GA; Schattner M
    IUBMB Life; 2011 Jul; 63(7):521-7. PubMed ID: 21698756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein VI - novel target in antiplatelet medication.
    Borst O; Gawaz M
    Pharmacol Ther; 2021 Jan; 217():107630. PubMed ID: 32681846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antiplatelet therapy for atherothrombotic disease: current evidence and new directions.
    White HD
    Am Heart J; 2011 Mar; 161(3):450-61. PubMed ID: 21392598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of platelets in thrombosis and hemostasis.
    Packham MA
    Can J Physiol Pharmacol; 1994 Mar; 72(3):278-84. PubMed ID: 8069774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preserved thrombin-inducible platelet activation in thienopyridine-treated patients.
    Gremmel T; Kopp CW; Seidinger D; Koppensteiner R; Steiner S; Panzer S
    Eur J Clin Invest; 2013 Jul; 43(7):689-97. PubMed ID: 23611368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the distinct mechanism of agonist-induced canine platelet activation.
    Chaudhary PK; Kim S
    J Vet Sci; 2019 Jan; 20(1):10-15. PubMed ID: 30541187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetics of antiplatelet drug resistance.
    Feher G; Feher A; Pusch G; Lupkovics G; Szapary L; Papp E
    Clin Genet; 2009 Jan; 75(1):1-18. PubMed ID: 19067731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between platelet function and recurrent ischemic vascular events after TIA and minor stroke
.
    Zhang J; Zhang J; Sun H; Ming T; Liu X; Cong Y; Li F; Li Z
    Int J Clin Pharmacol Ther; 2017 Oct; 55(10):789-797. PubMed ID: 28766499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.